Skip to main content
PMC home page
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2021 Mar 12;10:556654. doi: 10.3389/fcimb.2020.556654

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Co-Harboring blaKPC-Carrying Plasmid and pLVPK-Like Virulence Plasmid in Bloodstream Infections

Fang-ling Du 1,†, Qi-sen Huang 1,†, Dan-dan Wei 1, Yan-fang Mei 1, Dan Long 1, Wen-jian Liao 2, La-gen Wan 1, Yang Liu 1,*, Wei Zhang 2
PMCID: PMC7996060  PMID: 33777826

Abstract

This study aimed to characterize carbapenem-resistant Klebsiella pneumoniae (CR-KP) co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid. Between December 2017 and April 2018, 24 CR-KP isolates were recovered from 24 patients with bacteremia. The mortality was 66.7%. Pulsed-field gel electrophoresis and multilocus sequence typing results indicated four clusters, of which cluster A (n = 21, 87.5%) belonged to ST11 and the three remaining isolates (ST412, ST65, ST23) had different pulsotypes (cluster B, C, D). The bla KPC-2-carrying plasmids all belonged to IncFIIK type, and the size ranged from 100 to 390 kb. Nineteen strains (79.2%) had a 219-kb virulence plasmid possessed high similarity to pLVPK from CG43 with serotype K2. Two strains had a 224-kb virulence plasmid resembled plasmid pK2044 from K. pneumoniae NTUH-K2044(ST23). Moreover, three strains carried three different hybrid resistance- and virulence-encoding plasmids. Conjugation assays showed that both bla KPC-2 and rmpA2 genes could be successfully transferred to E. coli J53 in 62.5% of the strains at frequencies of 4.5 × 10−6 to 2.4 × 10−4, of which three co-transferred bla KPC-2 along with rmpA2 in large plasmids. Infection assays in the Galleria mellonella model demonstrated the virulence level of these isolates was found to be consistently higher than that of classic Klebsiella pneumoniae. In conclusion, CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid were characterized by multi-drug resistance, enhanced virulence, and transferability, and should, therefore, be regarded as a real superbug that could pose a serious threat to public health. Hence, heightened efforts are urgently needed to avoid its co-transmission of the virulent plasmid (gene) and resistant plasmid (gene) in clinical isolates.

Keywords: Klebsiella pneumonia, bloodstream infections, pLVPK-like virulence plasmid, KPC-2, carbapenem-resistant

Introduction

Carbapenem-resistant Klebsiella pneumoniae (CR-KP) has emerged as one of the most challenging pathogens in the latest years (Holt et al., 2015). CR-KP showed resistant to almost all available antibiotics and was related to limited treatment options and high mortality rates. CR-KP has been listed as a “critical priority” by the World Health Organization (WHO). For pathogen survival, the acquisition of virulent traits is necessary (Vila et al., 2011), and some reports suggest that the virulence of carbapenem-resistant Klebsiella pneumoniae is enhanced (Ferreira et al., 2018).

The virulence plasmid carrying major virulence genes such as capsular polysaccharides regulator genes (rmpA and rmpA2) and those encoding siderophores (eg, iroBCDN, iucABCD, iutA) were recognized as essential contributors to the virulence of hypervirulent Klebsiella pneumoniae (hvKP), and might serve as potential biomarkers for hvKP. The loss of this pLVPK-derived virulence plasmid significantly decreased virulence. Danxia Gu and colleagues (Gu et al., 2018) reported that CR-KP strains could further evolve to become carbapenem-resistant hvKP (CR-hvKP) through the acquisition of a pLVPK-like virulence plasmid. Meanwhile, CR-hvKP strains may emerge as a result of the acquisition of a carbapenemase-encoding plasmid by K1 or K2 hypervirulent Klebsiella pneumoniae (Zhang et al., 2016a). The emergence of carbapenem-resistant hypervirulent Klebsiella pneumonia(CR-hvKP) was due to the convergence of virulence and resistance. An increasing number of cases have also been observed worldwide. The high prevalence of carbapenem-resistant K pneumoniae (average 9.0% in 2017 and 15.4% in Jiangxi) and hypervirulent K pneumoniae (about 30–50%) (Zhang et al., 2016b; Liu and Guo, 2019) in Chinese hospitals may have contributed to the emergence of carbapenem-resistant and hypervirulent microorganism.

In the present study, we characterize clinical characteristics, clonal relationships, virulence and resistance potential of CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid in bloodstream infections. The findings of this study provide insight into the current prevalence and features of CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid in a Chinese hospital.

Materials and Methods

Bacterial Isolates and Antimicrobial Susceptibility Tests

Between December 2017 and April 2018, 24 CR-KP strains, which were identified by the VITEK 2 system (bioMérieux) and confirmed by 16S rRNA gene sequencing, were isolated from blood cultures of 24 patients hospitalized in the First Affiliated Hospital of Nanchang university (Nanchang), Southern China. Antimicrobial susceptibility testing was done for all isolates using Vitek 2 automated systems. Results were interpreted according to the Clinical and Laboratory Standards Institute (document M100-S27). Furthermore, antimicrobial susceptibility of tigecycline was performed by the broth microdilution method and interpreted by the recommendation of the European Committee on Antimicrobial Susceptibility Testing clinical breakpoints (http://www.eucast.org). Patient information was queried from the medical records. This study was approved by the ethical committee of the First Affiliated Hospital of Nanchang University. Informed consent was also obtained from all of the study patients.

Antimicrobial Resistance Genes

Polymerase chain reaction was used to detect carbapenemase-encoding genes (bla KPC, bla VIM, bla NDM, bla IMP, and bla OXA-48-like), β-lactamase genes (bla CTX-M, bla TEM, and bla SHV), plasmid-mediated quinolone resistance determinants (qnrA, qnrB, qnrS, aac(6′)-Ib-cr) and 16S rRNA methylase genes(armA, rmtB) as described previously (Liu et al., 2019). The positive PCR products were purified and sequenced, and the sequences alignments were compared to those in the NCBI database using BLAST.

Capsular Serotyping and Virulence-Associated Genes Detection

The capsular type of K. pneumoniae was determined by PCR and sequencing of wzi loci as previously described (Brisse et al., 2013). The sequences of products were compared to the wzi sequences deposited in the database of Institute Pasteur to identify the corresponding capsular types using BLAST program (https://bigsdb.pasteur.fr/klebsiella/klebsiella.html). Isolates were screened for the presence of 14 virulence-associated genes,including rmpA, rmpA2,terW, iutA, silS, mrkD, fimH, ybtS, entB, kpn, aerobactin, kfu, magA, and wcaG (Turton et al., 2018). Primers used for PCR are shown in Table S2 .

Plasmid Analysis and Plasmid Transfer

S1 nuclease-pulsed-field gel electrophoresis (S1-PFGE) and southern blotting hybridization were performed to determine the plasmid location of bla KPC-2-carrying plasmid and virulence plasmid (Xu et al., 2019). Briefly, total DNA was embedded in agarosegel plugs. The plugs were digested with S1 nuclease (TaKaRa) for 30 min at 37°C and then separated by eletrophoresis. Labeling of the probes ( Table S1 ) and hybridization were performed with the DIG-High Prime DNA Labeling and Detection Starter Kit II, according to the manufacturer’s instructions (Roche, Basle, Switzerland).

Conjugal transfer experiment was performed using broth-based methods with Escherichia coli J53 as the recipient strain. Donor and recipient cells were mixed at 2:1 donor-to-recipient ratio. Transconjugants were selected using 2 or 8 μg/ml potassium tellurite or 2 μg/ml meropenem plus 150 μg/ml sodium azide. Successful conjugation and transformation were confirmed by antimicrobial susceptibility and PCR detection of the bla KPC-2 gene and pLVPK-derived gene (rmpA, rmpA2, terW, iutA, silS). S1-PFGE was performed as described previously to confirm acquisition of this plasmid by the recipient strain.

Galleria Mellonella Infection Model

For virulence testing, the Galleria mellonella model was used to investigate toxicity. Ten larvae weighing between 250 and 350 mg (purchased from Tianjin Huiyude Biotech Company, Tianjin, China) were used for the assessment of the virulence level of each isolate. The insects were inoculated by injecting 1 × 106 CFU per 10 µl aliquot into the hemocoel via the rear left proleg using methods described previously (Mclaughlin et al., 2014), followed by a recording of survival rate every 12 h for 2 days. All experiments were performed in triplicates. The recent assessment of a range of K. pneumoniae isolates suggests the parameters for the Galleria model to define hypervirulence, based on a calculation of LD50 value (Shi et al., 2018). The hvKP strain NTUH-K2044 and K. pneumoniae strain ATCC700603 were used as controls of high and low virulence strains, respectively. Statistical analyses were performed and visualized with GraphPad Prism 7.00.

Multilocus Sequence Typing (MLST) and Pulsed-Field Gel Electrophoresis (PFGE)

MLST was performed by amplifying and sequencing the seven conserved housekeeping loci including gapA, infB, mdh, pgi, phoE, rpoB, and tonB (Diancourt et al., 2005), according to protocols on the Pasteur Institute MLST website (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html).

Clonal relatedness was established using XbaI-PFGE (Taraka). DNA fragments were separated with a CHEF DR III apparatus (Bio-Rad; Richmond, CA, USA). The molecular marker was Salmonella serotype Braenderup strain H9812. The isolates sharing >80% similarity were defined as the same PFGE cluster (Tenover et al., 1995).

Results

Patients and Bacterial Isolates

The clinical characteristics of the 24 patients with K. pneumoniae bacteremia are shown in Table 1 . These patients were mainly from the ICU (58.3%, n = 14). The mean age of the patients was 61.9 ± 16.6 years (range, 25–87 years) and 79.2% of these patients were males. The mean time of hospitalization from admission to the identification of CR-KP was 27.5 ± 16.5 days (range, 3–58 days). Hyperglycemia was found among eight cases (33.3%) and seven patients (29.2%) had hypertension. The majority of patients used various invasive procedures and devices, of which the usage rate of mechanical ventilation and tracheal intubation were highest (70.8%). All cases had received a wide variety of antibiotics in combination. The incidence rate of septic shock was 41.7%, and the mortality was 66.7%.

Table 1.

Clinical characteristics of patients with carbapenem-resistant K. pneumoniae bacteremia.

Demographics Prior antibiotic exposure
 Age (mean ± SD), years 61.9 ± 16.6 Carbapenem 24 (100.0)
 Gender, male 19(79.2) cephalosporin 3 (12.5)
 Length of stay (mean ± SD), days 27.5 ± 16.5 β-lactam and β-lactamase inhibitor 11(45.8)
Underlying disease Fluoroquinolone 9 (37.5)
 Diabetes mellitus 8(33.3) Aminoglycoside 8 (33.3)
 Hypertension 7(29.2) Tigecycline 11 (45.8)
Invasive procedures and devices Glycopeptide 14(58.3)
 Central venous catheter 13(54.2) Clinical outcomes
 Urinary catheter 14(58.3) Septic shock 10(41.7)
 Endotracheal tube 17(70.8) 30-day Mortality 16(66.7)
 Mechanical ventilation 17(70.8)
 Surgical drainage 11(45.8)
 Tracheostomy 5(20.8)
 Surgery 16(66.67)
Open in a new tab

Antimicrobial Susceptibility and Antimicrobial Resistance Genes

The detailed antimicrobial resistance profiles are shown in Table 2 . The antibiotic susceptibility test showed that all 24 isolates were resistant to ceftriaxone, cefotaxime, aztreonam, ertapenem, imipenem, and meropenem. The percentage of bacteria resistant to gentamicin (16.7%, n = 4), tobramycin (16.7%, n = 4), amikacin (12.5%, n = 3) is low. Resistant to ceftazidime (95.8%, n = 23), cefepime (95.8%, n = 23), piperacillin/tazobactam (91.7%, n = 22), levofloxacin (87.5%, n = 21), ciprofloxacin (87.5%, n = 21), and sulfamethoxazole-trimethoprim (95.8%, n = 23) was high. However, all isolates were sensitive to tigecycline.

Table 2.

Resistance genes and antibiotic susceptibilities of 24 CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid.

Isolates Resistance profile of K. pneumoniae Carbapenemase β-lactamase genes 16S rRNA methylase gene PMQR genes
Kp1 CRO,CAZ,CTX,FEP,TZP,ATM,GEN,TOB,AMK,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 TEM-1 – qnrB4
Kp2 CRO,CAZ,CTX,FEP,TZP,ATM,TOB,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 rmtB qnrS1,acc6-Ib-cr
Kp3 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM KPC-2 SHV,TEM-1,CTX-M-14 – acc6-Ib-cr
Kp4 CRO,CAZ,CTX,FEP,TZP,ATM,AMK,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14,15 – qnrS1,acc6-Ib-cr
Kp5 CRO,CAZ,CTX,FEP,TZP,ATM,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – –
Kp6 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM KPC-2 SHV-11,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp7 CRO,CAZ,CTX,FEP,TZP,ATM,GEN,TOB,AMK,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp8 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp9 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp10 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-11,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp11 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp12 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrB4,qnrS1,acc6-Ib-cr
Kp13 CRO,CAZ,CTX,FEP,TZP,ATM,GEN,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp14 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp15 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 TEM-1,CTX-M-14 – qnrS1
Kp16 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-11,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp17 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-11,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp18 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14,-15 – qnrS1,acc6-Ib-cr
Kp19 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp20 CRO,CAZ,CTX,FEP,ATM,LVX,CIP,ETP,IMP,MEM KPC-2 SHV-11,TEM-1,CTX-M-14 – qnrS1,acc6-Ib-cr
Kp21 CRO,CAZ,CTX,FEP,TZP,ATM,ETP,IMP,MEM KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1
Kp22 CRO,CAZ,CTX,FEP,TZP,ATM,GEN,TOB,AMK,LVX,CIP,ETP,IMP,MEM,SXT KPC-2 SHV-12,TEM-1,CTX-M-14,-15 – qnrS1
Kp23 CRO,CAZ,CTX,FEP,TZP,ATM,LVX,CIP,ETP,IMP,MEM,TGC,SXT KPC-2 SHV-12,TEM-1,CTX-M-14 – qnrS1
Kp24 CRO,CTX,ATM,ETP,IMP,MEM KPC-2 CTX-M-14 – –
Open in a new tab

CRO, ceftriaxone; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; TZP, piperacillin/tazobactam; ATM, Aztreonam; GEN, gentamicin; TOB, Tobramycin; AMK, amikacin; LVX, Levofloxacin; CIP, ciprofloxacin; ETP, Ertapenem; IMP, imipenem; MEM, meropenem; SXT, trimethoprim-sulfamethoxazole.

All the 24 isolates were positive for bla KPC-2 gene. The β-lactamase genes were detected, including bla TEM-1 (95.8%, n = 23), bla CTX-M-15 (95.8%, n = 23), and bla SHV-11 (79.2%, n = 19). In addition, 20 isolates (83.3%) carried qnrS1, 17 isolates carried aac(6’)-Ib-cr (70.8%) and 2 isolates (8.3%) carried qnrB4. However, only one isolate carried plasmid-mediated 16S rRNA methylase gene rmtB. All isolates were negative for bla VIM, bla NDM, bla IMP, bla OXA-48, armA, and qnrS.

Plasmid Profiles

Plasmid location of bla KPC-carrying plasmid and pLVPK-like virulence plasmid was determined by S1-PFGE and Southern blot analysis. The results demonstrated that the plasmid size carrying bla KPC-2 ranged from 100 to 390 kb ( Figures 1 , S1 ). Furthermore, two isolates had two different plasmids harboring bla KPC-2 gene. Nineteen strains (79.2%) had a 219-kb virulence plasmid possessed high similarity to previously reported pLVPK from Klebsiella pneumoniae CG43 with serotype K2. Two strains had a 224-kb virulence plasmid resembled plasmid pK2044 from K. pneumoniae NTUH-K2044 belonged to sequence type 23. Moreover, there were three isolates (KP3, KP5, KP6) carrying a hybrid resistance- and virulence-encoding plasmid, which harbored both the carbapenemase gene bla KPC-2 and the virulence gene rmpA2.

Figure 1.

Figure 1

Open in a new tab

The S1-PFGE and Southern hybridization analysis of 3 strains hybrid resistance- and virulence-encoding plasmids. Notes: (A) S1 nuclease digestion of genomic DNA of K. pneumoniae strains was followed by PFGE. Plasmid bands are shown as linearized fragment on the gel. (B) Southern blot hybridization of bla KPC-2 gene. Mark it with a red arrow. (C) Southern blot hybridization of the marker gene (rmpA2) of the virulence plasmid. Mark it with a blue arrow. Lane M, reference standard strain Salmonella serotype Braenderup H9812 restricted with Xbal. M, marker; S1-PFGE, S1 nuclease pulsed-field gel electrophoresis.

Conjugation assays showed that both bla KPC-2 and rmpA2 genes could be successfully transferred to E. coli J53 in 62.5% (15/24) of the strains at frequencies of 4.5 × 10−6 to 2.4 × 10−4 (transconjugant/recipient), of which three co-transferred bla KPC-2 along with rmpA2 in large plasmids. KP3 isolate transferred a hybrid resistance- and virulence-encoding plasmid of 390 kb to E. coli J53 at a frequency of 3.5 × 10−5 (transconjugant/recipient) by mating. In addition, KP10 and KP24 isolates co-transferred the bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid to E. coli J53 at a frequency of 7.4 × 10−6 (transconjugant/recipient) by mating ( Table S3 ).

Virulence-Associated Features

The prevalence and distribution of virulence factors are shown in Figure 2A . The virulence-related genes detected in 24 isolates included fimH-1 (100%), mrkD (100%), ybtS (91.7%), entB (83.3%), kpn (83.3%), aerobactin (62.5%), kfu (20.8%), magA (12.5%), and wcaG (8.3%) ( Figure S2 ). Moreover, all the five pLVPK-derived locus, rmpA, rmpA2, terW, iutA, silS, were detected in all 24 isolates.

Figure 2.

Figure 2

Open in a new tab

(A) The distributions of virulence-associated genes among CR-KP co-harboring blaKPC-2-carrying plasmid and pLVPK-like virulence plasmid. (B) Virulence potential of representative CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid in a Galleria mellonella infection model. CR-KP, carbapenem-resistant Klebsiella pneumoniae.

The G. mellonella larvae infection model was used to assess the potential virulence of these isolates ( Figure 2B ). After 48 h of infection, the mortality of the larvae infected with CR-KP isolates co-carrying virulence plasmid and KPC-2 plasmid were consistently higher than that infected with cKP (P < 0.05) ( Table S2 ). Among the 24 strains, the virulence level of 15 isolates is similar to hvKP previously reported (P>0.05), but nine isolates are less virulent (P < 0.05) ( Table S2 ).

Clonal Relationship

Among the 24 isolates, four STs were identified, including ST11 (14 wzi47-K47 isolates, five wzi64-K64 isolates, and two wzi125-K1 isolates), ST23 (1 wzi1-K1 isolate), ST65 (1 wzi2-K2 isolate), ST412 (1 wzi206-K57 isolate). PFGE ( Figure 1 ) identified one major pulsotype (cluster A), encompassing 21 of the 24 isolates, all belonging to ST11 ( Figure 3 ). The three remaining isolates (Kp20, Kp21, and Kp24) had different pulsotypes.

Figure 3.

Figure 3

Open in a new tab

PFGE dendrogram of 24 carbapenem-resistant Klebsiella pneumoniae co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid. ICU, intensive care unit; ND, neurosurgery department; GD, gastroenterology department; ID, infectious department.

Discussion

In our study, we reported the prevalence of carbapenem-resistant K. pneumoniae co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid in patients with bacteremia. Klebsiella pneumoniae is the second most common pathogen in Enterobacteriaceae bloodstream infections (Meatherall et al., 2009). In this study, the overall 30-day mortality rate was 66.7%, which was higher than in those with KPC-producing K. pneumoniae bloodstream infections (44.2%) (Xu et al., 2018). Ten patients (41.7%) developed septic shock, which was the recognized reason for increased mortality (Falcone et al., 2016). In addition, 33.3% of the patients had hyperglycemia, which was considered to be a significant risk factor for hypervirulent Klebsiella pneumoniae infection (Zhang et al., 2016b). There are many possible contributing factors to the emergence, rise, and spread of antibiotic resistance, including ICU admission, antibiotics exposure, using invasive devices and procedures (Li et al., 2019). These risk factors may have contributed to the high rates of antibiotic resistance found in our study.

Although all the 24 CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid were multi-drug-resistant, amikacin, gentamicin, and tigecycline still had efficient antimicrobial activity in vitro against these isolates, indicating that they could be valuable treatment choices. The production of Klebsiella pneumoniae carbapenemase (KPC) is the most prevalent mechanism of resistance to carbapenems (Munoz-Price et al., 2013). In China, the first detection of the plasmid-mediated class A carbapenemase KPC-2 gene was located on an approximately 60-kb plasmid in 2007 (Wei et al., 2007). In this study, the bla KPC-2 carrying plasmids all belonged to IncFIIK type, and the size ranged from 100-kb to 390-kb.

Virulence plasmids were associated with hypervirulent serotypes of Klebsiella pneumoniae and predisposed patients to abscess formation (Tang et al., 2010). In the present study, nineteen strains (79.2%) carry a 219-kb virulence plasmid similar to pLVPK plasmid from serotype K2, K. pneumoniae CG43 (Chen et al., 2004). Two strains (8.3%) carry a 224-kb virulence plasmid similar to the pK2044 plasmid from serotype K1, sequence type (ST) 23 strain NTUH-K2044 (Wu et al., 2009). The pLVPK-like virulence plasmids in K. pneumoniae are very large and would, therefore, be regarded as non-conjugative. This would explain their strong association with particular hypervirulent serotypes (Struve et al., 2015). Nevertheless, it is obvious that virulence plasmids have been reported in several serotypes of Klebsiella, indicating that conjugation is occurring, albeit at a low frequency. In this study, three strains CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid can transfer virulence plasmids to E. coli J53. The conjugative transfer of this virulence plasmid increased the virulence level of such strain.

Carbapenem-resistant K. pneumoniae rarely carry virulence plasmids and hypervirulent K. pneumoniae generally do not carry antibiotic resistance genes. Nevertheless, in the current study, 24 strains Klebsiella pneumoniae co- harbored bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid. Most recently, Dong et al. (2018) reported that a bla KPC-2-encoding element can be integrated into a virulence plasmid, which then possesses the ability to mediate expression of both hypervirulence and hyper-resistance phenotype in K1 hypervirulent Klebsiella pneumoniae. Similarly, we found three strains ST11 K. pneumoniae carrying a bla KPC-2-harboring virulence plasmid, which were approximately 390, 270, and 170 kb, respectively. The convergence of virulence and MDR in a single plasmid vector enables simultaneous transfer and potentially rapid emergence of hypervirulence-MDR K. pneumoniae clones.

The presence of mrkD and fimH has previously been related to KPC-positive K. pneumoniae (De Cassia Andrade Melo et al., 2014). However, previous studies (Yeh et al., 2007) reported that magA was characteristic of the K1 capsular operon, which was associated with the hypermucoviscosity phenotype of K. pneumoniae. Siderophore-associated genes, such as entB, ybtS, and iutA, were critical for bacterial growth, replication, and virulence (Holden and Bachman, 2015). entB was only characterized for virulence when it occurs in association with iutA or ybtS (Daehre et al., 2018). By analyzing virulence genes, all K. pneumoniae isolates carried both mrkD and fimH genes in our study. Moreover, the entB, iutA or ybtS genes were present from three-quarters of all isolates, all of which serve as high mark of virulence.

Capsule, lipopolysaccharide (LPS), fimbriae (types 1 and 3), siderophores, and pLVPK-like virulence plasmid are virulence factors that contribute to the pathogenicity of K. pneumoniae. Nevertheless, Shu et al. (2019) reported OXA-232-producing ST15 carbapenem-resistant K. pneumoniae were not hypervirulent despite harboring a virulence plasmid. In the current study, the virulence level of CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid was found to be consistently higher than that of cKP. But we also found nine strains CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid were less virulent than hvKP. Further studies are required to establish the relationship between the hypervirulence phenotype and the carriage of the virulence plasmid in K. pneumoniae.

In our study, 87.5% of CR-KP co-harboring bla KPC-2-carrying plasmid and pLVPK-like virulence plasmid belonged to ST11, in accordance with the report by Qi et al. (2011), which described that ST11 was the dominant clone of KPC-2-producing K. pneumoniae in China. Nineteen out of twenty-one ST11 isolates were wzi47-K47 or wzi64-K64 by the capsular serotyping. Two ST11 isolates belonged to wzi125-K1, which was rarely reported in a previous study (Wei et al., 2016). One wzi1-K1 strain belonged to ST23, was strongly correlated with liver abscess (Shon et al., 2013); one wzi2-K2 strain belonged to ST65, which is in accordance with the previous study that ST65 was the most common ST associated with K2 serotype in K. pneumoniae (Liao et al., 2014); one wzi206-K57 belonged to ST412, which was hypermucoviscous.

In conclusion, all isolates were characterized by multi-drug resistance, enhanced virulence, and transferability, and should, therefore, be regarded as a real superbug that could pose a serious threat to public health. Moreover, three strains carried 3 different hybrid resistance- and virulence-encoding plasmids. We should strengthen the ability of anti-infective prophylaxis and management to avoid its co-transmission of the virulent plasmid (gene) and resistant plasmid (gene) in clinical isolates.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

This study was approved by the ethical committee of the First Affiliated Hospital of Nanchang University. Informed consent was also obtained from all of the study patients.

Author Contributions

F-lD, Q-sH, D-dW, and YL conceived and designed the experiments. F-lD, Q-sH, D-dW, DL, and W-jL designed and performed the experiments. F-lD, L-gW, and WZ analyzed the data. F-lD and YL wrote the manuscript. YL contributed to review on data analysis and the interpretation of the data. All authors contributed to the article and approved the submitted version.

Funding

This study was supported by the National Natural Science Foundation of China (81560323), Education Department of Jiangxi Province, China (180016), Jiangxi science and Technology Department in China (20202ZDB01016, 20202ACBL206025, 20181BAB205065 and 20202ACBL206023) and Health and Family Planning Commission of Jiangxi Province (20188006 and 2018A330).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2020.556654/full#supplementary-material

Click here for additional data file. (997.3KB, docx)

References

  1. Brisse S., Passet V., Haugaard A. B., Babosan A., Kassis-Chikhani N., Struve C., et al. (2013). wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J. Clin. Microbiol. 51, 4073–4078. 10.1128/JCM.01924-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen Y. T., Chang H. Y., Lai Y. C., Pan C. C., Tsai S. F., Peng H. L. (2004). Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337, 189–198. 10.1016/j.gene.2004.05.008 [DOI] [PubMed] [Google Scholar]
  3. Daehre K., Projahn M., Friese A., Semmler T., Guenther S., Roesler U. H. (2018). ESBL-Producing Klebsiella pneumoniae in the Broiler Production Chain and the First Description of ST3128. Front. Microbiol. 9, 2302–2307. 10.3389/fmicb.2018.02302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Cassia Andrade Melo R., De Barros E. M., Loureiro N. G., De Melo H. R., Maciel M. A., Souza Lopes A. C. (2014). Presence of fimH, mrkD, and irp2 virulence genes in KPC-2-producing Klebsiella pneumoniae isolates in Recife-PE, Brazil. Curr. Microbiol. 69, 824–831. 10.1007/s00284-014-0662-0 [DOI] [PubMed] [Google Scholar]
  5. Diancourt L., Passet V., Verhoef J., Grimont P. A., Brisse S. (2005). Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43, 4178–4182. 10.1128/JCM.43.8.4178-4182.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dong N., Lin D., Zhang R., Chan E. W., Chen S. (2018). Carriage of blaKPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J. Antimicrob. Chemother. 73, 3317–3321. 10.1093/jac/dky358 [DOI] [PubMed] [Google Scholar]
  7. Falcone M., Russo A., Iacovelli A., Restuccia G., Ceccarelli G., Giordano A., et al. (2016). Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin. Microbiol. Infect. 22, 444–450. 10.1016/j.cmi.2016.01.016 [DOI] [PubMed] [Google Scholar]
  8. Ferreira R. L., Da Silva B. C. M., Rezende G. S., Nakamura-Silva R., Pitondo-Silva A., Campanini E. B., et al. (2018). High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and beta-Lactamase Encoding Genes in a Brazilian Intensive Care Unit. Front. Microbiol. 9, 3198. 10.3389/fmicb.2018.03198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gu D., Dong N., Zheng Z., Lin D., Huang M., Wang L., et al. (2018). A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect. Dis. 18, 37–46. 10.1016/S1473-3099(17)30489-9 [DOI] [PubMed] [Google Scholar]
  10. Holden V. I., Bachman M. A. (2015). Diverging roles of bacterial siderophores during infection. Metallomics 7, 986–995. 10.1039/C4MT00333K [DOI] [PubMed] [Google Scholar]
  11. Holt K. E., Wertheim H., Zadoks R. N., Baker S., Whitehouse C. A., Dance D., et al. (2015). Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. U. S. A. 112, E3574–E3581. 10.1073/pnas.1501049112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Li J., Li Y., Song N., Chen Y. (2019). Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. J. Glob. Antimicrob. Resist. 21, 306–313. 10.1016/j.jgar.2019.09.006 [DOI] [PubMed] [Google Scholar]
  13. Liao C. H., Huang Y. T., Chang C. Y., Hsu H. S., Hsueh P. R. (2014). Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. Eur. J. Clin. Microbiol. Infect. Dis. 33, 365–369. 10.1007/s10096-013-1964-z [DOI] [PubMed] [Google Scholar]
  14. Liu C., Guo J. (2019). Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor. Ann. Clin. Microbiol. Antimicrob. 18, 4. 10.1186/s12941-018-0302-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liu Y., Du F. L., Xiang T. X., Wan L. G., Wei D. D., Cao X. W., et al. (2019). High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants Among Serotype K1 Hypervirulent Klebsiella pneumoniae Isolates in China. Microb. Drug Resist. 10.1089/mdr.2018.0173 [DOI] [PubMed] [Google Scholar]
  16. Mclaughlin M. M., Advincula M. R., Malczynski M., Barajas G., Qi C., Scheetz M. H. (2014). Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC Infect. Dis. 14, 31. 10.1186/1471-2334-14-31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meatherall B. L., Gregson D., Ross T., Pitout J. D., Laupland K. B. (2009). Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am. J. Med. 122, 866–873. 10.1016/j.amjmed.2009.03.034 [DOI] [PubMed] [Google Scholar]
  18. Munoz-Price L. S., Poirel L., Bonomo R. A., Schwaber M. J., Daikos G. L., Cormican M., et al. (2013). Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13, 785–796. 10.1016/S1473-3099(13)70190-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Qi Y., Wei Z., Ji S., Du X., Shen P., Yu Y. (2011). ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J. Antimicrob. Chemother. 66, 307–312. 10.1093/jac/dkq431 [DOI] [PubMed] [Google Scholar]
  20. Shi Q., Lan P., Huang D., Hua X., Jiang Y., Zhou J., et al. (2018). Diversity of virulence level phenotype of hypervirulent Klebsiella pneumoniae from different sequence type lineage. BMC Microbiol. 18, 94. 10.1186/s12866-018-1236-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shon A. S., Bajwa R. P., Russo T. A. (2013). Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4, 107–118. 10.4161/viru.22718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shu L., Dong N., Lu J., Zheng Z., Hu J., Zeng W., et al. (2019). Emergence of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae That Carries a pLVPK-Like Virulence Plasmid among Elderly Patients in China. Antimicrob. Agents Chemother. 63 (3), e02246–18. 10.1128/AAC.02246-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Struve C., Roe C. C., Stegger M., Stahlhut S. G., Hansen D. S., Engelthaler D. M., et al. (2015). Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. MBio 6, e00630. 10.1128/mBio.00630-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tang H. L., Chiang M. K., Liou W. J., Chen Y. T., Peng H. L., Chiou C. S., et al. (2010). Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur. J. Clin. Microbiol. Infect. Dis. 29, 689–698. 10.1007/s10096-010-0915-1 [DOI] [PubMed] [Google Scholar]
  25. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233–2239. 10.1128/JCM.33.9.2233-2239.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Turton J. F., Payne Z., Coward A., Hopkins K. L., Turton J. A., Doumith M., et al. (2018). Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383. J. Med. Microbiol. 67, 118–128. 10.1099/jmm.0.000653 [DOI] [PubMed] [Google Scholar]
  27. Vila A., Cassata A., Pagella H., Amadio C., Yeh K. M., Chang F. Y., et al. (2011). Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis. Open Microbiol. J. 5, 107–113. 10.2174/1874285801105010107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wei Z. Q., Du X. X., Yu Y. S., Shen P., Chen Y. G., Li L. J. (2007). Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob. Agents Chemother. 51, 763–765. 10.1128/AAC.01053-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wei D. D., Wan L. G., Deng Q., Liu Y. (2016). Emergence of KPC-producing Klebsiella pneumoniae hypervirulent clone of capsular serotype K1 that belongs to sequence type 11 in Mainland China. Diagn. Microbiol. Infect. Dis. 85, 192–194. 10.1016/j.diagmicrobio.2015.03.012 [DOI] [PubMed] [Google Scholar]
  30. Wu K. M., Li L. H., Yan J. J., Tsao N., Liao T. L., Tsai H. C., et al. (2009). Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J. Bacteriol. 191, 4492–4501. 10.1128/JB.00315-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Xu M., Fu Y., Kong H., Chen X., Chen Y., Li L., et al. (2018). Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome. BMC Infect. Dis. 18, 358. 10.1186/s12879-018-3263-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Xu M., Fu Y., Fang Y., Xu H., Kong H., Liu Y., et al. (2019). High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China. Infect. Drug Resist. 12, 641–653. 10.2147/IDR.S191892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yeh K. M., Kurup A., Siu L. K., Koh Y. L., Fung C. P., Lin J. C., et al. (2007). Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J. Clin. Microbiol. 45, 466–471. 10.1128/JCM.01150-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhang R., Lin D., Chan E. W., Gu D., Chen G. X., Chen S. (2016. a). Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China. Antimicrob. Agents Chemother. 60, 709–711. 10.1128/AAC.02173-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zhang Y., Zhao C., Wang Q., Wang X., Chen H., Li H., et al. (2016. b). High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance. Antimicrob. Agents Chemother. 60, 6115–6120. 10.1128/AAC.01127-16 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (997.3KB, docx)

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES